|
Highlights from PAS: Rare Disorders - Don't Miss a Treatable Disease
Target Audience
This activity is designed to meet the educational needs of neonatologists, pediatricians, geneticists, family practice, registered nurses, nurse practitioners, physician assistants, genetic counselors, and other HCPs who wish to improve their knowledge and competence in identifying and managing patients with treatable rare disorders through NBS as well as other measures.
Program Overview
This activity will feature clinical cases where newborn screening (NBS) identified a t... |
|
Managing Obesity in Adolescent Patients Your Top 10 Questions Answered
The rate of obesity in children and adolescents is increasing, posing significant physical and mental health challenges through childhood and adolescence and into adulthood. Recently, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been approved for use in patients as young as 12 years, and it is critical that clinicians initiate both lifestyle management and pharmacologic therapies as early as possible. Dr. Fatima Stanford discusses 10 common questions asked about managing obesity ... |
|
Hypertrophic Cardiomyopathy: Unmasking Disparities and Forging a Path to Equitable Care
This comprehensive continuing education (CE) monograph delves into the complexities of HCM, an autosomal dominant genetic disorder marked by increased left ventricular hypertrophy. This condition can lead to significant health complications, such as heart failure, arrhythmias, stroke, and sudden cardiac death. Despite the impact of HCM on patient health and well-being, a gap persists in the understanding of the racial/ethnic and gender-based disparities among healthcare professionals. This gap... |
|
Hypertrophic Cardiomyopathy: Unmasking Disparities and Forging a Path to Equitable Care
This comprehensive continuing education (CE) monograph delves into the complexities of HCM, an autosomal dominant genetic disorder marked by increased left ventricular hypertrophy. This condition can lead to significant health complications, such as heart failure, arrhythmias, stroke, and sudden cardiac death. Despite the impact of HCM on patient health and well-being, a gap persists in the understanding of the racial/ethnic and gender-based disparities among healthcare professionals. This gap... |
|
5th International Conference on Cardiology
We are delighted to invite you to the 5th International Conference on Cardiology, from November 28-29, 2025 in Paris, France where ground-breaking discoveries and advancements in cardiac care will take center stage under the theme “Exploring New Horizons in Cardiology and Research”
Heart 2025 conference highlights the new innovative technology in cardiovascular medicine, cardio diseases, paediatric and adolescent cardiology, cardio surgery, cardiac nursing, interventional cardiology, ge... |